FIELD: medicine.
SUBSTANCE: group of inventions refers to veterinary and deals with treatment or prevention of inflammatory bowel disease (IBD) in cat. For this purpose therapeutically efficient amount of docosahexaenoic acid (DHA) or DHA in combination with one or several fatty acids, selected from group consisting of eicosapentaenoic acid, linolenic and alpha-linolenic acids. Preliminarily presence of IBD is determined by dynamics of lymphocyte proliferation in cat's blood samples including in DHA presence.
EFFECT: inventions ensure efficient IBD treatment due to reduction of CD4+ lymphocytes and neutrophils in cats with IBD.
26 cl, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS CONTAINING GINGER FOR MITIGATION OR PREVENTION OF INFLAMMATORY CONDITIONS | 2010 |
|
RU2534891C2 |
| PET FOOD COMPOSITIONS | 2016 |
|
RU2727670C1 |
| METHOD OF INTESTINE FLORA MODIFICATION IN ANIMALS | 2006 |
|
RU2426451C2 |
| TREATMENT OF INTESTINE DYSFUNCTION IN HIV PATIENTS | 2005 |
|
RU2403048C2 |
| INTESTINAL BARRIER INTEGRITY IMPROVEMENT | 2004 |
|
RU2402240C2 |
| NUTRITIONAL COMPOSITION CONTAINING 2'FUCOSYLLACTOSE AND 3'GALACTOSYLLACTOSE | 2020 |
|
RU2818570C2 |
| COUNTER-DIARRHEA COMPOSITION CONTAINING GLUTAMINE | 2004 |
|
RU2370098C2 |
| METHODS AND COMPOSITIONS FOR PREVENTION AND TREATMENT OF INFLAMMATORY DISEASE | 2006 |
|
RU2416399C2 |
| IMMUNITY-STIMULATING BABY FOOD | 2005 |
|
RU2426549C2 |
| MCT-BASED NUTRITIONAL FORMULA FOR PROVIDING HEALTH EFFECTS IN ANIMALS | 2020 |
|
RU2831143C2 |
